Johnson & Johnson Price to Free Cash Flow Ratio 2006-2021 | JNJ

Historical price to free cash flow ratio values for Johnson & Johnson (JNJ) since 2006. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2021-09-17 164.75 18.79
2021-06-30 163.76 $8.77 18.67
2021-03-31 162.37 $8.14 19.95
2020-12-31 154.52 $7.67 20.14
2020-09-30 145.15 $6.91 21.01
2020-06-30 136.20 $6.65 20.49
2020-03-31 126.12 $8.50 14.83
2019-12-31 139.39 $8.64 16.14
2019-09-30 122.78 $9.35 13.14
2019-06-30 132.18 $8.74 15.12
2019-03-31 131.76 $8.04 16.38
2018-12-31 120.84 $7.97 15.17
2018-09-30 128.56 $7.48 17.19
2018-06-30 112.15 $7.70 14.57
2018-03-31 117.58 $7.36 15.97
2017-12-31 127.38 $7.14 17.83
2017-09-30 117.81 $7.11 16.57
2017-06-30 119.12 $6.62 17.99
2017-03-31 111.41 $6.33 17.60
2016-12-31 102.39 $6.03 16.99
2016-09-30 104.26 $5.86 17.78
2016-06-30 106.35 $6.19 17.17
2016-03-31 94.20 $6.66 14.15
2015-12-31 88.79 $6.96 12.76
2015-09-30 80.10 $6.13 13.07
2015-06-30 82.98 $6.80 12.20
2015-03-31 85.03 $6.56 12.96
2014-12-31 87.77 $6.85 12.81
2014-09-30 88.89 $6.76 13.16
2014-06-30 86.66 $5.83 14.88
2014-03-31 80.81 $5.49 14.71
2013-12-31 74.80 $4.96 15.07
2013-09-30 70.31 $4.94 14.25
2013-06-30 69.13 $4.71 14.67
2013-03-31 65.15 $4.64 14.04
2012-12-31 55.57 $4.97 11.19
2012-09-30 54.15 $5.02 10.79
2012-06-30 52.61 $5.05 10.42
2012-03-31 50.88 $4.83 10.54
2011-12-31 50.14 $4.59 10.92
2011-09-30 48.25 $4.62 10.43
2011-06-30 49.95 $4.71 10.61
2011-03-31 44.10 $4.72 9.35
2010-12-31 45.63 $5.21 8.76
2010-09-30 45.32 $5.76 7.87
2010-06-30 42.79 $5.69 7.52
2010-03-31 46.81 $5.50 8.51
2009-12-31 45.89 $5.15 8.91
2009-09-30 43.05 $4.77 9.03
2009-06-30 39.84 $4.60 8.66
2009-03-31 36.56 $4.36 8.38
2008-12-31 41.24 $4.48 9.22
2008-09-30 47.38 $4.28 11.08
2008-06-30 43.72 $4.03 10.85
2008-03-31 43.78 $4.05 10.81
2007-12-31 44.72 $4.31 10.38
2007-09-30 43.78 $4.49 9.76
2007-06-30 40.78 $4.49 9.08
2007-03-31 39.62 $4.30 9.20
2006-12-31 43.16 $4.08 10.57
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $434.939B $82.584B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $319.781B 0.00
Pfizer (PFE) United States $249.329B 14.16
Novo Nordisk (NVO) Denmark $241.084B 33.46
Eli Lilly (LLY) United States $221.573B 28.77
AbbVie (ABBV) United States $190.996B 9.15
Novartis AG (NVS) Switzerland $188.736B 14.02
Merck (MRK) United States $182.183B 12.47
AstraZeneca (AZN) United Kingdom $175.360B 24.93
Sanofi (SNY) $121.515B 13.39
GlaxoSmithKline (GSK) United Kingdom $105.307B 13.21
Bayer (BAYRY) Germany $52.972B 7.13
H Lundbeck (HLUYY) Denmark $5.383B 10.32
Innoviva (INVA) United States $1.059B 5.69